Northwire Canada EditionSunday, July 19, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Regulatory

Vitalist Inc. Commences Trading on the OTCQB Venture Market Under the Ticker "VTLSF"

By The Northwire Desk — AI Analysis Oct 08, 2025 · 20:25 VITA · 1.12 Vitalist Inc.
VITA · Price

Executive Summary

  • Vitalist Inc. announced that its common shares have begun trading on the U.S. OTCQB Venture Market under the ticker VTLSF, while continuing to trade on the TSX Venture Exchange as VITA.
  • The cross‑listing is intended to broaden access for U.S. investors, improve liquidity and visibility, and support the company’s anticipated growth initiatives.
  • The listing subjects Vitalist to OTCQB reporting and verification standards, enhancing its governance profile.

Key Details

  • Listing Platforms:
  • Primary: TSX Venture Exchange (symbol VITA)

  • Secondary: OTCQB Venture Market (symbol VTLSF)

  • Strategic Rationale:

  • Enables U.S. investors and financial institutions to trade and settle Vitalist shares more easily.

  • Expected to increase share liquidity, broaden the shareholder base, and attract institutional capital.

  • Regulatory Requirements:

  • Must meet OTCQB’s high financial and governance standards, stay current in reporting, and undergo annual verification and management certification.

  • Executive Comment:

  • CFO David Colleran stated that the listing “marks a significant moment” and will “enhance liquidity and visibility for our shareholders” while supporting future growth.

  • Forward‑Looking Statements:

  • The release contains forward‑looking information regarding the benefits of the OTCQB listing, subject to risks and uncertainties outlined in Vitalist’s most recent MD&A on SEDAR.

Notable Quotes

“Listing on the OTCQB marks a significant moment for Vitalist as we expand our reach to the U.S. capital markets. This strategic move will enhance liquidity and visibility for our shareholders and broaden our appeal to a more diverse investor base, including institutional investors, as well as support our anticipated future growth.” – David Colleran, Chief Financial Officer

Materiality Assessment: Material – Positive (the cross‑listing is a material corporate development that positively impacts liquidity, market exposure, and potential capital access).

Read the original news release →

More from Vitalist Inc.

Jun 16, 2026 · 08:30

Vitalist's medical pivot continues to generate partnerships, but revenue scale and negative equity remain the overriding constraints.

M&A / Property Apr 30, 2026 · 14:58

Vitalist Closes Somatix Acquisition Amidst Dilution Concerns and Debt Extension

M&A / Property Mar 31, 2026 · 07:00

Vitalist Bets on Medical AI Acquisition While Cash Reserves Dwindle and Debt Looms

M&A / Property Feb 09, 2026 · 07:03

Vitalist and MicroEJ Partner with BENIO to Launch First VitalOS(TM) Powered Smartwatch in Asia

M&A / Property Feb 04, 2026 · 07:03

Vitalist Inc. Partners with Pattern to Accelerate Global E-Commerce Growth for Reebok Smartwatches

M&A / Property Dec 05, 2025 · 07:31

Vitalist Secures Facer for VitalOS

M&A / Property